PARP inhibitors: the race is on

Br J Cancer. 2016 Mar 29;114(7):713-5. doi: 10.1038/bjc.2016.67.

Authors

Jessica S Brown^{1

2}, Stan B Kaye^{1

2}, Timothy A Yap^{1

2}

Affiliations

¹ Drug Development Unit, Royal Marsden Hospital, London, UK.
² Division of Clinical Studies, The Institute of Cancer Research, London, UK.

No abstract available

Publication types

Editorial
Comment

MeSH terms

BRCA1 Protein / genetics*
BRCA2 Protein / genetics*
Breast Neoplasms / drug therapy*
Female
Germ-Line Mutation / genetics*
Humans
Indoles / therapeutic use*
Ovarian Neoplasms / drug therapy*

Substances

BRCA1 Protein
BRCA2 Protein
Indoles